An in vivo small-molecule drug screen in developing zebrafish larvae identifies dozens of unique chemical modulators capable of reducing atherogenic apolipoprotein B levels.
The next wave of food innovation: 7 start-ups to watch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results